CST3 and acute kidney injury: Effective management of intraoperative hematocrit levels and the preemptive use of vasopressin are promising strategies for reducing AKI risk by optimizing renal perfusion and function during cardiac surgery. Early detection through biomarkers like cystatin C and NGAL offers the potential for timely intervention and better patient outcomes.